Market and Product Forecasts: Multiple Sclerosis - New drugs to radically change treatment algorithm and grow market

Market and Product Forecasts: Multiple Sclerosis – New drugs to radically change treatment algorithm and grow market

The seven major multiple sclerosis markets is expected to show slight value growth from 2011 to 2020 at a CAGR of 1.7% to generate $10.0 billion at the end of this period. This growth will be driven by drugs offering improved efficacy and a less invasive method of administration than current treatments.

By 2020, the US will remain the biggest marketplace for multiple sclerosis drug developers at $6.9bn. The UK and Japan are set to remain the smallest of the seven major markets at $111m and $200 in 2020. High hurdles, such as NICE, have restricted market access and availability in the UK.

With a convenient mode of administration and improved efficacy, sales of Novartis’s Gilenya and Biogen’s BG-12 are expected to overtake older brands and become the highest-selling multiple sclerosis drugs with seven major market sales of $2.2bn and $1.2bn, respectively, in 2020.

Request a Sample for or Inquire before buying the report @
http://www.reportsnreports.com/reports/143436-market-and-product-forecasts-multiple-sclerosis-new-drugs-to-radically-change-treatment-algorithm-and-grow-market.html

Features and benefits

• Access Datamonitor’s patient-based multiple sclerosis market forecast, with transparent methodologies and assumptions across the seven major markets.
• Evaluate sales value and volume forecasts to 2020 at the country, class, product, and indication level for disease modifying and symptomatic therapies
• Understand how market drivers and resistors will shape the future market dynamics.
• Quantify the impact of new products launches by understanding Datamonitor’s assumptions on launch dates, pricing, and penetration rates.

Explore Comprehensive list of more than Tables & Figures available in the report Market and Product Forecasts: Multiple Sclerosis – New drugs to radically change treatment algorithm and grow market